Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

NCT06741111 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06741111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06741111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
January 21, 2025
Completion date
May 27, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease (masld) & steatohepatitis (mash)